FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction

by Ture Lange Nielsen, Louis Lind Plesner, Peder Emil Warming, Ole Hartvig Mortensen, Kasper Karmark Iversen, James Goya Heaf
Published 2019-05-01

FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction

by Ture Lange Nielsen, Louis Lind Plesner, Peder Emil Warming, Ole Hartvig Mortensen, Kasper Karmark Iversen, James Goya Heaf
Published 2019-05-01

Atherosclerosis Imaging with ¹⁸F-Sodium Fluoride PET

by Poul F. Høilund-Carlsen, Reza Piri, Caius Constantinescu, Kasper Karmark Iversen, Thomas J. Werner, Michael Sturek, Abass Alavi, Oke Gerke
Published 2020-10-01

Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants

by Rafael Bayarri-Olmos, Ida Jarlhelt, Laust Bruun Johnsen, Cecilie Bo Hansen, Charlotte Helgstrand, Jais Rose Bjelke, Finn Matthiesen, Susanne Dam Nielsen, Susanne Dam Nielsen, Kasper Karmark Iversen, Kasper Karmark Iversen, Sisse Rye Ostrowski, Sisse Rye Ostrowski, Henning Bundgaard, Henning Bundgaard, Ruth Frikke-Schmidt, Ruth Frikke-Schmidt, Peter Garred, Peter Garred, Mikkel-Ole Skjoedt, Mikkel-Ole Skjoedt
Published 2021-10-01

Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial

by Per Winkel, Jørgen Hilden, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv, Christian Gluud, Kasper Karmark Iversen, Gorm Boje Jensen, Mette Bjerre
Published 2020-08-01

Risk assessment models for potential use in the emergency department have lower predictive ability in older patients compared to the middle-aged for short-term mortality – a retros...

by Martin Schultz, Line Jee Hartmann Rasmussen, Nicolas Carlson, Rasmus Bo Hasselbalch, Birgitte Nybo Jensen, Lotte Usinger, Jesper Eugen-Olsen, Christian Torp-Pedersen, Lars Simon Rasmussen, Kasper Karmark Iversen
Published 2019-05-01

Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)

by Martin Schultz, Line Jee Hartmann Rasmussen, Malene H. Andersen, Jakob S. Stefansson, Alexander C. Falkentoft, Morten Alstrup, Andreas Sandø, Sarah L. K. Holle, Jeppe Meyer, Peter B. S. Törnkvist, Thomas Høi-Hansen, Erik Kjøller, Birgitte Nybo Jensen, Morten Lind, Lisbet Ravn, Thomas Kallemose, Theis Lange, Lars Køber, Lars Simon Rasmussen, Jesper Eugen-Olsen, Kasper Karmark Iversen
Published 2018-08-01